Literature DB >> 20359695

Compensation and disease severity on the memory-related activations in mild cognitive impairment.

Francis Clément1, Sylvie Belleville.   

Abstract

BACKGROUND: Alzheimer's disease is a neurodegenerative disease with progressive cognitive impairments that are likely to affect the compensatory mechanisms and the cerebral activation patterns of the patients.
METHODS: Functional neuroimaging was used to test the effect of disease severity on the brain activation of persons at risk for Alzheimer's disease and to highlight the process of compensation in some of these individuals. This was done for the verbal learning of either semantically related or semantically unrelated word pairs. Twenty-six persons with mild cognitive impairment (MCI) were separated into two groups, MCI higher-cognition and MCI lower-cognition, with a split-median on their scores for the Mattis Dementia Rating Scale. A group of 14 healthy older adults were matched to the MCI participants.
RESULTS: In both task conditions, MCI higher-cognition activated additional regions, relative to control subjects, in the right ventrolateral and dorsolateral prefrontal brain areas. Additional areas of hyperactivation were found in the right prefrontal area 45 when encoding semantically related word pairs and in the left hippocampus during encoding of unrelated word pairs. In contrast, MCI lower-cognition failed to show additional prefrontal activations when compared with healthy control subjects and showed decreased activation in posterior areas.
CONCLUSIONS: These results are in line with compensation occurring at the beginning of the MCI continuum and with the breakdown of compensation in patients experiencing more severe symptoms.
Copyright © 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20359695     DOI: 10.1016/j.biopsych.2010.02.004

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  39 in total

1.  Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease.

Authors:  Orestes Vicente Forlenza; Breno Satler Diniz; Antonio Lucio Teixeira; Marcia Radanovic; Leda Leme Talib; Natalia Pessoa Rocha; Wagner Farid Gattaz
Journal:  Neuromolecular Med       Date:  2015-07-03       Impact factor: 3.843

Review 2.  Functional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Jasmeer P Chhatwal; Reisa A Sperling
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Task-evoked pupil dilation and BOLD variance as indicators of locus coeruleus dysfunction.

Authors:  Jeremy A Elman; Matthew S Panizzon; Donald J Hagler; Lisa T Eyler; Eric L Granholm; Christine Fennema-Notestine; Michael J Lyons; Linda K McEvoy; Carol E Franz; Anders M Dale; William S Kremen
Journal:  Cortex       Date:  2017-10-07       Impact factor: 4.027

Review 4.  Effects of hypoperfusion in Alzheimer's disease.

Authors:  Benjamin P Austin; Veena A Nair; Timothy B Meier; Guofan Xu; Howard A Rowley; Cynthia M Carlsson; Sterling C Johnson; Vivek Prabhakaran
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 5.  Toward systems neuroscience in mild cognitive impairment and Alzheimer's disease: a meta-analysis of 75 fMRI studies.

Authors:  Hui-Jie Li; Xiao-Hui Hou; Han-Hui Liu; Chun-Lin Yue; Yong He; Xi-Nian Zuo
Journal:  Hum Brain Mapp       Date:  2014-11-19       Impact factor: 5.038

6.  Brain's compensatory response to drug-induced cognitive impairment.

Authors:  Immanuel Babu Henry Samuel; Christopher Barkley; Susan E Marino; Chao Wang; Sahng-Min Han; Angela K Birnbaum; Jean E Cibula; Mingzhou Ding
Journal:  J Clin Exp Neuropsychol       Date:  2018-05-02       Impact factor: 2.475

7.  Cerebral blood flow is an earlier indicator of perfusion abnormalities than cerebral blood volume in Alzheimer's disease.

Authors:  María Lacalle-Aurioles; José M Mateos-Pérez; Juan A Guzmán-De-Villoria; Javier Olazarán; Isabel Cruz-Orduña; Yasser Alemán-Gómez; María-Elena Martino; Manuel Desco
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-15       Impact factor: 6.200

8.  Maintenance, reserve and compensation: the cognitive neuroscience of healthy ageing.

Authors:  Roberto Cabeza; Marilyn Albert; Sylvie Belleville; Fergus I M Craik; Audrey Duarte; Cheryl L Grady; Ulman Lindenberger; Lars Nyberg; Denise C Park; Patricia A Reuter-Lorenz; Michael D Rugg; Jason Steffener; M Natasha Rajah
Journal:  Nat Rev Neurosci       Date:  2018-11       Impact factor: 34.870

9.  Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates.

Authors:  Susan K Conroy; Brenna C McDonald; Tim A Ahles; John D West; Andrew J Saykin
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

10.  Biomarkers of Cognitive Training Effects in Aging.

Authors:  Sylvie Belleville; Louis Bherer
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2012-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.